Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
Get the Alerts
Claim MarketBeat All Access Sale Promotion

The Clorox Company $CLX Shares Acquired by Assenagon Asset Management S.A.

Clorox logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Assenagon Asset Management S.A. grew its stake in The Clorox Company (NYSE:CLX - Free Report) by 117.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 64,990 shares of the company's stock after buying an additional 35,149 shares during the period. Assenagon Asset Management S.A. owned 0.05% of Clorox worth $5,265,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Retirement Planning Co of New England Inc. raised its stake in Clorox by 19.9% during the third quarter. Retirement Planning Co of New England Inc. now owns 7,434 shares of the company's stock worth $602,000 after buying an additional 1,232 shares during the last quarter. Mystic Asset Management Inc. boosted its position in Clorox by 1.3% during the third quarter. Mystic Asset Management Inc. now owns 12,112 shares of the company's stock valued at $981,000 after acquiring an additional 153 shares during the last quarter. State of Alaska Department of Revenue boosted its position in Clorox by 174.5% during the third quarter. State of Alaska Department of Revenue now owns 32,518 shares of the company's stock valued at $2,634,000 after acquiring an additional 20,670 shares during the last quarter. Chiron Capital Management LLC grew its holdings in Clorox by 177.1% during the 3rd quarter. Chiron Capital Management LLC now owns 9,701 shares of the company's stock worth $786,000 after acquiring an additional 6,200 shares during the period. Finally, Mather Group LLC. grew its holdings in Clorox by 8,799.9% during the 3rd quarter. Mather Group LLC. now owns 137,503 shares of the company's stock worth $11,139,000 after acquiring an additional 135,958 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft reissued a "hold" rating and issued a $95.00 price objective on shares of Clorox in a research report on Monday. Morgan Stanley reduced their price objective on shares of Clorox from $97.00 to $87.00 and set an "equal weight" rating for the company in a research report on Thursday, October 15th. Citigroup reduced their price objective on shares of Clorox from $97.00 to $90.00 and set a "neutral" rating for the company in a research report on Wednesday, October 14th. JPMorgan Chase & Co. lowered their price objective on shares of Clorox from $95.00 to $83.00 and set an "underweight" rating for the company in a research note on Monday. Finally, Wall Street Zen cut shares of Clorox from a "hold" rating to a "sell" rating in a report on Saturday, October 3rd. Twelve investment analysts have rated the stock with a Hold rating and four have issued a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Reduce" and a consensus price target of $93.57.

Get Our Latest Analysis on CLX

Clorox Stock Up 2.3%

CLX stock opened at $87.50 on Wednesday. The Clorox Company has a twelve month low of $79.12 and a twelve month high of $128.90. The company has a quick ratio of 0.38, a current ratio of 0.66 and a debt-to-equity ratio of 15.80. The stock's 50 day moving average is $91.41 and its 200-day moving average is $94.99. The firm has a market capitalization of $10.58 billion, a PE ratio of 18.15, a P/E/G ratio of 2.71 and a beta of 0.59.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Monday, August 3rd. The company reported $1.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.02. Clorox had a return on equity of 522.23% and a net margin of 8.74%. The business had revenue of $1.95 billion during the quarter, compared to the consensus estimate of $1.91 billion. During the same quarter in the prior year, the company posted $2.87 earnings per share. Clorox's revenue was down 2.0% compared to the same quarter last year. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. Sell-side analysts expect that The Clorox Company will post 5.74 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Wednesday, October 28th will be paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 5.7%. The ex-dividend date is Wednesday, October 28th. Clorox's dividend payout ratio is 103.73%.

Clorox Profile

(Free Report)

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt's Bees personal care items.

Featured Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines